Things I read over the weekend as part of my stock research activities.
New Orders Received
🟢 CE Info Systems secured a major ₹110.19 Cr contract from Indian Oil Corporation for a 5-year centralized vehicle tracking system.
🟢 Vikran Engineering Ltd secured large solar EPC orders (including ~₹ 354 crore for a 100 MW project).
🟢 RVNL received a work order worth ₹144 Cr, adding to its infrastructure project portfolio.
🟢 Swan Defence and Heavy Industries signed a letter of intent for constructing six 18,000 DWT chemical tankers.
🟢 RDB Infrastructure & Power Ltd entered an MOU for 51 MW AC / 65 MW DC solar projects (across 5–6 sites near Nagpur) with an EPC contract value of ₹ 277 crore.
Core Business & Regulatory
🟢 Swiggy food-delivery business growing at ~18.8 % YoY in gross order value. Quick-commerce arm Instamart saw ~108 % YoY Revenue growth. Adjusted EBITDA margin in food-delivery improved to ~2.8 % of GOV.
🟢 Lords Chloro Alkali commissioned a 16MW solar plant at Bikaner, entered a 10MW hybrid power pact, and proposed a 21MW solar plus 100TPD sulphuric acid project, with ₹355 Cr capex. Looking to double capacity by FY28.
🟢 Gujarat Themis Biosyn Ltd is expanding fermentation capacity to 990 KL, integrating a new API facility and commencing commercial production of RIFA-S/O to enhance its pharma output.
🟢 Dynamatic Technologies launched the world’s first AI-enabled inspection for Airbus A220 doors.
🟢 JK Tyre launched India’s first tyres with embedded sensors for passenger cars, enhancing safety and performance monitoring.
Partnerships & Acquisitons
🟢 Syrma SGS Technology is acquiring a 60% stake in Elcome Integrated Systems to expand into defence and maritime electronics.
🟢 Dreamfolks Services completed the acquisition of a 50.01% stake in Ten 11 Hospitality LLP, making it a subsidiary to bolster its hospitality offerings.
🟢 Paisalo Digital formed co-lending partnerships with SBI, UBI, and Axis Bank to expand rural financial inclusion through digital lending and AI-based credit analytics.
🟢 Novo Nordisk partnered with Emcure Pharma to commercialise Poviztra, its semaglutide injection for weight loss, in India as a second brand of Wegovy.
Company Results
That’s it for today.
FINVEZTO.COM | Build Wealth, Systematically
At Finvezto Stock Research (Anand Ganapathy, SEBI Registered RA), we offer the following services. Do check out more details below.
Long Term Recommendations (Core Portfolio)
Medium Term Recommendations (Satellite Portfolio)
Short Term Strategies (Overlay Portfolio)
Toolkit for Stock Research (For DIY Investors & Traders)
Disclaimer: Anand Ganapathy K is a SEBI-registered Research Analyst with SEBI registration number INH000016630. This post is purely for learning purposes to understand more about the business. It does not recommend buying or selling stocks mentioned in this newsletter. Securities market investments carry market risks. Kindly review all related documents before investing.